100 related articles for article (PubMed ID: 35377034)
1. Validation of a quantitative lateral flow immunoassay (LFIA)-based point-of-care (POC) rapid test for SARS-CoV-2 neutralizing antibodies.
Pieri M; Nicolai E; Nuccetelli M; Sarubbi S; Tomassetti F; Pelagalli M; Minieri M; Terrinoni A; Bernardini S
Arch Virol; 2022 May; 167(5):1285-1291. PubMed ID: 35377034
[TBL] [Abstract][Full Text] [Related]
2. Direct capture of neutralized RBD enables rapid point-of-care assessment of SARS-CoV-2 neutralizing antibody titer.
Connelly GG; Kirkland OO; Bohannon S; Lim DC; Wilson RM; Richards EJ; Tay DM; Jee H; Hellinger RD; Hoang NK; Hao L; Chhabra A; Martin-Alonso C; Tan EKW; Koehler AN; Yaffe MB; London WB; Lee PY; Krammer F; Bohannon RC; Bhatia SN; Sikes HD; Li H
Cell Rep Methods; 2022 Aug; 2(8):100273. PubMed ID: 35942328
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence-Quenching Lateral Flow Immunoassay for "Turn-On" and Sensitive Detection of Anti-SARS-Cov-2 Neutralizing Antibodies in Human Serum.
Bian L; Fu Q; Gan Z; Wu Z; Song Y; Xiong Y; Hu F; Zheng L
Adv Sci (Weinh); 2024 Jan; 11(4):e2305774. PubMed ID: 38032112
[TBL] [Abstract][Full Text] [Related]
4. Point of care detection of SARS-CoV-2 antibodies and neutralisation capacity-lateral flow immunoassay evaluation compared to commercial assay to inform potential role in therapeutic and surveillance practices.
McGrath J; O'Doherty L; Conlon N; Dunne J; Brady G; Ibrahim A; McCormack W; Walsh C; Domegan L; Walsh S; Kenny C; Allen N; Fleming C; Bergin C
Front Public Health; 2023; 11():1245464. PubMed ID: 37841735
[TBL] [Abstract][Full Text] [Related]
5. A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2.
Fulford TS; Van H; Gherardin NA; Zheng S; Ciula M; Drummer HE; Redmond S; Tan HX; Boo I; Center RJ; Li F; Grimley SL; Wines BD; Nguyen THO; Mordant FL; Ellenberg P; Rowntree LC; Kedzierski L; Cheng AC; Doolan DL; Matthews G; Bond K; Hogarth PM; McQuilten Z; Subbarao K; Kedzierska K; Juno JA; Wheatley AK; Kent SJ; Williamson DA; Purcell DFJ; Anderson DA; Godfrey DI
EBioMedicine; 2021 Dec; 74():103729. PubMed ID: 34871960
[TBL] [Abstract][Full Text] [Related]
6. [COVID-19 vaccination at the University of Alicante (Spain): detection of neutralizing antibodies against SARS-CoV-2 by rapid serological test, a cross-sectional study].
Montagud AC; Vicente-Alcalde N; Gabaldón-Bravo EM; Hurtado-Sánchez JA; Montagud E; Egoavil CM; Chavarría-Alarcón E; Caballero P; Tuells J
Rev Esp Salud Publica; 2023 Dec; 97():. PubMed ID: 38126466
[TBL] [Abstract][Full Text] [Related]
7. Rapid lateral flow tests for the detection of SARS-CoV-2 neutralizing antibodies.
Wang JJ; Zhang N; Richardson SA; Wu JV
Expert Rev Mol Diagn; 2021 Apr; 21(4):363-370. PubMed ID: 33840347
[No Abstract] [Full Text] [Related]
8. Overlaid Lateral Flow Immunoassay for the Simultaneous Detection of Two Variant-Specific SARS-CoV-2 Neutralizing Antibodies.
Deenin W; Khongchareonporn N; Ruxrungtham K; Ketloy C; Hirankarn N; Wangkanont K; Rengpipat S; Yakoh A; Chaiyo S
Anal Chem; 2024 Apr; 96(14):5407-5415. PubMed ID: 38478766
[TBL] [Abstract][Full Text] [Related]
9. A systematic and meta-analysis review on the diagnostic accuracy of antibodies in the serological diagnosis of COVID-19.
Vengesai A; Midzi H; Kasambala M; Mutandadzi H; Mduluza-Jokonya TL; Rusakaniko S; Mutapi F; Naicker T; Mduluza T
Syst Rev; 2021 May; 10(1):155. PubMed ID: 34039423
[TBL] [Abstract][Full Text] [Related]
10. Validity of Self-testing at Home With Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Detection by Lateral Flow Immunoassay.
Atchison CJ; Moshe M; Brown JC; Whitaker M; Wong NCK; Bharath AA; McKendry RA; Darzi A; Ashby D; Donnelly CA; Riley S; Elliott P; Barclay WS; Cooke GS; Ward H
Clin Infect Dis; 2023 Feb; 76(4):658-666. PubMed ID: 35913410
[TBL] [Abstract][Full Text] [Related]
11. Development of a quantum dot-based lateral flow immunoassay strip for rapid and sensitive detection of SARS-CoV-2 neutralizing antibodies.
Wang X; Shao S; Ye H; Li S; Gu B; Tang B
Sci Rep; 2023 Dec; 13(1):22253. PubMed ID: 38097611
[TBL] [Abstract][Full Text] [Related]
12. The value of serum neutralizing antibody in evaluating predictability of COVID-19 after recovery and the validation of vaccine.
Guo B; Li Z; Fu G; Li H; Yang J; Zhang Z; Wu L; Wang J
BMC Infect Dis; 2023 Dec; 23(1):895. PubMed ID: 38124038
[TBL] [Abstract][Full Text] [Related]
13. The utility of smartphone-based quantitative analysis of SARS-CoV-2-specific antibody lateral flow assays.
Uwamino Y; Tanaka S; Shibata A; Kurafuji T; Ishihara H; Sato Y; Matsushita H
Diagn Microbiol Infect Dis; 2024 Mar; 108(3):116166. PubMed ID: 38157638
[TBL] [Abstract][Full Text] [Related]
14. Determination of optimum levels of binding antibody units (BAU) of new quantitative chemiluminescent immuno-assay (CLIA) in COVID-19 vaccinated volunteer blood donors.
Tiwari AK; Aggarwal G; Kale P; Yadav N; Kumar V; Singh G; Cheirmaraj K; Krishnan K
Transfus Apher Sci; 2024 Jun; 63(3):103937. PubMed ID: 38678985
[TBL] [Abstract][Full Text] [Related]
15. Use of a point-of-care test to rapidly assess levels of SARS-CoV-2 nasal neutralising antibodies in vaccines and breakthrough infected individuals.
Tan CW; Lim CK; Prestedge J; Batty M; Mah YY; O'Han M; Wang LF; Kilby D; Anderson DE
Sci Rep; 2023 Nov; 13(1):20263. PubMed ID: 37985674
[TBL] [Abstract][Full Text] [Related]
16. Development of automated microfluidic immunoassays for the detection of SARS-CoV-2 antibodies and antigen.
Johnson L; Bartlett ML; Ramirez F; Heger CD; Smith DR
J Immunol Methods; 2024 Jan; 524():113586. PubMed ID: 38040191
[TBL] [Abstract][Full Text] [Related]
17. Next-Generation Rapid and Ultrasensitive Lateral Flow Immunoassay for Detection of SARS-CoV-2 Variants.
Lin C; Liu Z; Fang F; Zhao S; Li Y; Xu M; Peng Y; Chen H; Yuan F; Zhang W; Zhang X; Teng Z; Xiao R; Yang Y
ACS Sens; 2023 Oct; 8(10):3733-3743. PubMed ID: 37675933
[TBL] [Abstract][Full Text] [Related]
18. Quartz Crystal Microbalance Platform for SARS-CoV-2 Immuno-Diagnostics.
Nilsson PH; Al-Majdoub M; Ibrahim A; Aseel O; Suriyanarayanan S; Andersson L; Fostock S; Aastrup T; Tjernberg I; Rydén I; Nicholls IA
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069027
[TBL] [Abstract][Full Text] [Related]
19. A semi-quantitative visual lateral flow immunoassay for SARS-CoV-2 antibody detection for the follow-up of immune response to vaccination or recovery.
Cavalera S; Di Nardo F; Serra T; Testa V; Baggiani C; Rosati S; Colitti B; Brienza L; Colasanto I; Nogarol C; Cosseddu D; Guiotto C; Anfossi L
J Mater Chem B; 2024 Feb; 12(8):2139-2149. PubMed ID: 38315042
[TBL] [Abstract][Full Text] [Related]
20. A rapid simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies.
Kongsuphol P; Jia H; Cheng HL; Gu Y; Shunmuganathan BD; Chen MW; Lim SM; Ng SY; Tambyah PA; Nasir H; Gao X; Tay D; Kim S; Gupta R; Qian X; Kozma MM; Purushotorman K; McBee ME; MacAry PA; Sikes HD; Preiser PR
Commun Med (Lond); 2021; 1():46. PubMed ID: 35602218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
